A decompression implant for osteonecrosis
Through the spiral shaft and control system of the osteonecrosis decompression implantation device, dynamic auxiliary blood supply to the femur is achieved, solving the treatment problem of early-stage avascular necrosis of the femoral head, improving treatment efficacy and ease of operation, and extending the service life of the femoral head.
Patent Information
- Application Number
- CN202521582513.8
- Authority / Receiving Office
- CN · China
- Patent Type
- Utility models(China)
- Current Assignee / Owner
- Filing Date
- 2025-07-28
- Publication Date
- 2026-11-10
- Estimated Expiration
- 2035-07-28
AI Technical Summary
Existing surgical techniques for treating early-stage avascular necrosis of the femoral head have varying efficacy, making it difficult to provide effective and timely treatment. This often leads to the need for artificial hip replacement in later stages, increasing the difficulty of treatment.
The osteonecrosis decompression implantation device actively draws blood from the outside of the femur into the inside through a spiral shaft to achieve dynamic assisted blood supply. Combined with a controller, sensing device and monitoring element, it realizes automated and precise blood delivery and physiological status monitoring.
It improves blood supply within the femur, enhances the stability and ease of operation of the implant, provides flexible blood supply control and real-time physiological feedback, extends the lifespan of the femoral head, and reduces the need for hip replacement.
Smart Images

Figure CN224949047U_ABST
Abstract
Description
Technical Field
[0001] This utility model relates to the field of medical device technology, and in particular to a decompression implantation device for osteonecrosis. Background Technology
[0002] As the largest weight-bearing joint in the human body, the femoral head has a relatively weak blood supply and few vascular anastomoses, making it prone to ischemia. When it suffers from trauma, hormones, alcohol, blood disorders, or other diseases, the blood vessels supplying the femoral head are easily damaged, leading to local blood circulation disorders. This affects the timely removal of bone metabolic products, creating a vicious cycle that can cause ischemic necrosis of the femoral head.
[0003] Avascular necrosis of the femoral head is a disease caused by various factors (such as trauma, hormones, alcohol, etc.) leading to insufficient blood supply to the femoral head, bone tissue degeneration and necrosis, and fracture and dissolution of bone trabeculae. If left untreated, collapse of the weight-bearing femoral head can cause joint dysfunction, necessitating total hip replacement in later stages. However, artificial joints have a limited lifespan. For young patients with high activity levels and long life expectancies, revision surgery may be required multiple times throughout their lives, increasing the difficulty of treatment. Therefore, timely and effective treatment of early-stage avascular necrosis of the femoral head, extending the lifespan of the femoral head itself, and delaying hip replacement is a pressing clinical challenge.
[0004] Currently, there are many surgical treatment methods for early-stage avascular necrosis of the femoral head, including core drilling decompression, bone implantation, osteotomy, bone transplantation, and stem cell transplantation. Clinical efficacy reports vary, and each method has its drawbacks. Summary of the Invention
[0005] To address the aforementioned technical problems, this utility model provides a decompression implantation device for osteonecrosis, which actively draws blood from outside the femur into the femur through a spiral shaft, achieving a dynamic auxiliary blood supply effect.
[0006] To achieve the above objectives, the present invention adopts the following technical solution: A decompression implant for osteonecrosis, comprising: A tube, one end of which is open and the other end is sealed, is used for implantation into the femur, while the open end connects to the outside of the femur; the outer edge of the tube also has a drainage hole, which is located inside the femur; and A spiral delivery assembly includes a spiral shaft and a drive component. The spiral shaft is disposed inside the tube body, and the drive component is disposed inside the sealed end. The drive component drives the spiral shaft to rotate, and the rotation of the spiral shaft causes blood from the open end to enter the tube body and then enter the interior of the femur through the leakage hole.
[0007] In one possible implementation, the implantable device further includes a controller and a sensing device, wherein the controller is controlled to the drive unit and the sensing device is electrically connected to the controller; The controller controls the start and stop of the drive component based on the sensing information from the sensing device.
[0008] In one possible implementation, the sensing device includes a timer.
[0009] In one possible implementation, the sensing device includes a communication module and a mobile terminal. The communication module is disposed on the tube body and is electrically connected to the controller. The communication module is also communicatively connected to the mobile terminal.
[0010] In one possible implementation, a power supply assembly for supplying power is also included, the power supply assembly being disposed inside the sealed end.
[0011] In one possible implementation, the implantable device further includes a monitoring element for monitoring blood oxygen concentration, pH, and temperature within the femur, and the monitoring element is electrically connected to the communication module.
[0012] In one possible implementation, the outer edge of the tube is provided with a threaded positioning section, which is used to connect with the femoral thread.
[0013] In one possible implementation, the leakage holes are spaced in multiples.
[0014] In one possible implementation, the sealing end is provided with a guide angle on its exterior.
[0015] In one possible implementation, the monitoring element is disposed outside the sealed end.
[0016] This utility model has the following advantages due to the adoption of the above technical solution: After the implantation device is inserted, the drive unit is activated, which rotates the transmission screw shaft. The rotation of the screw shaft causes the blood at the open end to enter the tube and then enter the interior of the femur through the leakage hole, thereby achieving the effect of auxiliary blood supply and increasing the blood supply inside the femur. Once the implantable device is fully installed, when medical staff need it for assisted blood supply, they only need to remotely control the drive unit via NFC connection from outside the body. When the communication module recognizes the communication signal, the controller controls the start and stop of the drive unit to achieve assisted blood supply. The monitoring element is used to monitor the blood oxygen concentration, pH, and temperature inside the femur, facilitating medical staff to assess the patient's condition. It has the advantages of high flexibility and accurate feedback. Through the spiral delivery component, the device can effectively guide blood from inside the femur into the tube, promote blood flow, increase blood supply to the femur, and help bone tissue recovery. The design of the outer threaded positioning section enhances the threaded connection between the implant and the femur, ensuring implant stability and reducing the risk of displacement; The guide tilt design at the sealed end simplifies the implantation process and improves the operational efficiency of medical staff; Multiple evenly distributed drainage holes can more effectively provide auxiliary blood supply, ensuring that the blood supply to every area inside the femur is guaranteed; The design, which combines controllers and sensors, allows medical staff to set timed blood supply, is highly automated, easy to operate, and improves the flexibility of use. The NFC function of the communication module allows medical staff to remotely control the blood supply process via mobile terminals, improving the convenience of operation. The integrated monitoring elements can monitor blood oxygen concentration, pH level and temperature, and provide real-time feedback on the patient's physiological status, helping medical staff to make timely assessments and adjust treatment plans. The use of high-energy-density lithium polymer batteries ensures long-term power supply for the device, and the surface is coated with biocompatible silicone to prevent leakage and ensure high safety. Attached Figure Description
[0017] Figure 1 This is a schematic diagram of the specific structure of the osteonecrosis decompression implantation device in one embodiment of the present invention; Figure 2 This is a schematic diagram of the internal structure of the osteonecrosis decompression implantation device in one embodiment of the present invention; Figure 3 This is a schematic diagram illustrating the specific principle of the communication module in one embodiment of the present invention; Figure 4 This is a schematic diagram illustrating the specific principle of the monitoring element in one embodiment of the present invention; Figure 5 This is a schematic diagram illustrating the specific principle of the spiral shaft in one embodiment of the present invention; Figure label: 1. Pipe body; 2. Open end; 3. Sealed end; 4. Leakage hole; 5. Spiral shaft; 6. Drive component; 7. Threaded positioning section; 8. Guide tilt angle; 9. Monitoring element. Detailed Implementation
[0018] To make the objectives, technical solutions, and advantages of this utility model clearer, the technical solutions of this utility model are described clearly and completely below. Obviously, the described embodiments are only some embodiments of this utility model, not all embodiments. Based on the embodiments of this utility model, all other embodiments obtained by those skilled in the art without creative effort are within the scope of protection of this invention.
[0019] Unless otherwise defined, the technical or scientific terms used in this invention shall have the ordinary meaning understood by one of ordinary skill in the art to which this invention pertains. The terms "first," "second," "third," "fourth," and similar words used in this invention do not indicate any order, quantity, or importance, but are merely used to distinguish different components. Terms such as "comprising" or "including" mean that the element or object preceding the word encompasses the elements or objects listed following the word and their equivalents, without excluding other elements or objects. Terms such as "connected" or "linked" are not limited to physical or mechanical connections, but can include electrical connections, whether direct or indirect.
[0020] Avascular necrosis of the femoral head is a disease caused by ischemia, degeneration, and necrosis of the femoral head due to the above-mentioned reasons, resulting in fracture and dissolution of trabecular bone, deformation or collapse of the weight-bearing area, and often leading to disability and joint dysfunction in its late stages. As the disease progresses, the destruction of the weight-bearing femoral head leads to subchondral bone necrosis and collapse of the articular cartilage, causing joint dysfunction and ultimately requiring total hip replacement. However, artificial joints have a certain lifespan. For young patients with high activity levels and long life expectancy, revision surgery may be required multiple times throughout their lives, making joint replacement not the first-line treatment for early-stage avascular necrosis of the femoral head. Therefore, timely and effective treatment of early-stage avascular necrosis of the femoral head, extending the lifespan of the femoral head itself, and delaying the need for hip replacement are urgent clinical challenges that need to be addressed.
[0021] Currently, there are numerous surgical treatment methods for early-stage avascular necrosis of the femoral head, including core drilling decompression, bone implantation, osteotomy, bone transplantation, and stem cell transplantation. Clinical efficacy reports vary, and each method has its drawbacks. To address these technical problems, this invention provides a decompression implantation device for osteonecrosis. This device uses a spiral shaft to draw blood from outside the femur into the interior of the femur, achieving an auxiliary blood supply effect. The technical solution of this invention will be described in detail below with specific examples.
[0022] Reference Figure 1 as well as Figure 2 As shown, the osteonecrosis decompression implantation device involved in this utility model includes a tube body 1 and a spiral delivery assembly.
[0023] One end of the tube 1 is an open end 2, and the other end is a sealed end 3. The tube 1 is used to be implanted inside the femur, while the open end 2 is used to connect to the outside of the femur. The outer edge of the tube 1 is also provided with a leakage hole 4, which is located inside the femur.
[0024] Simultaneously refer to Figure 5 As shown, the spiral delivery assembly includes a spiral shaft 5 and a drive component 6. The spiral shaft 5 is located inside the tube body 1, and the drive component 6 is located inside the sealed end 3. The drive component 6 drives the spiral shaft 5 to rotate, and the rotation of the spiral shaft 5 causes the blood at the open end 2 to enter the tube body 1 and enter the interior of the femur through the leakage hole 4.
[0025] For example, after the implantation device is inserted, the drive unit 6 is activated, which rotates the transmission screw shaft 5. The rotation of the screw shaft 5 causes the blood at the open end 2 to enter the tube body 1 and enter the interior of the femur through the leakage hole 4, thereby achieving the effect of auxiliary blood supply and increasing the blood supply inside the femur.
[0026] In one embodiment, more preferably, a threaded positioning section 7 is provided on the outer edge of the tube body 1, the threaded positioning section 7 being used for connection with the femoral thread.
[0027] In addition, in this embodiment, a guide angle 8 is provided on the outside of the sealing end 3 to facilitate the installation of the implantation device.
[0028] The threaded positioning section 7 can strengthen the positioning and fixation structure with the femur, making the installation structure of the implanted device more stable.
[0029] In one embodiment, more preferably, in order to optimize the auxiliary blood supply effect of the implantation device, multiple leakage holes 4 are provided at intervals. Specifically, the leakage holes 4 are evenly spaced along the circumference of the tube body 1.
[0030] In one embodiment, the implantation device further includes a controller and a sensing device. The controller is controlled to the drive unit 6, and the sensing device is electrically connected to the controller. The controller controls the drive unit 6 to start and stop according to the sensing information from the sensing device.
[0031] Specifically, in this embodiment, the sensing device includes a timer, which medical staff can preset a time value to activate the driver 6 at a set time for auxiliary blood supply.
[0032] In another embodiment, the sensing device includes a communication module and a mobile terminal. The communication module is disposed on the tube body 1 and is electrically connected to the controller. The communication module is also communicatively connected to the mobile terminal.
[0033] Reference Figure 3 as well as Figure 4As shown, specifically in this embodiment, the communication module is an NFC sensor (specifically, the NFC coil located at the open end 2 shown in the figure), and the mobile terminal is an NFC-enabled mobile phone. The mobile terminal and the communication module transmit control signals through radio electromagnetic coupling.
[0034] For example, when an implantable device is needed for assisted blood supply, the mobile terminal is brought close to the communication module. When the communication module detects the communication signal, the controller controls the start and stop of the drive component 6 to achieve assisted blood supply. Medical personnel can also preset the start and stop time of the drive component 6 for each cycle to achieve intermittent assisted blood supply; the communication module controls the start and stop of the drive component 6 when it detects the communication signal.
[0035] More preferably, in this embodiment, a power supply component for power supply is also included, and in order to optimize the overall component layout, the power supply component is located inside the sealed end 3.
[0036] Specifically, the power supply component is a high-energy-density lithium polymer battery (capacity 50 mAh, lifespan 5 years), encapsulated on the outside of the open end, with the surface coated with biocompatible silicone to prevent leakage.
[0037] In one extended embodiment, the implantation device further includes a monitoring element 9 for monitoring the blood oxygen concentration, pH value and temperature value inside the femur. The monitoring element 9 is electrically connected to the communication module and is disposed outside the sealed end 3.
[0038] The monitoring element 9 integrates a blood oxygen sensor, a pH sensor, and a temperature sensor. The monitoring element 9 is electrically connected to the controller. The monitoring element 9 can collect biological information (blood oxygen concentration, pH, and temperature) inside the femur according to a preset timing plan and store the information. External devices can read the data via NFC so that medical staff can understand the specific situation inside the femur in a timely manner and make adaptive adjustments according to the patient's actual needs.
[0039] For example, after the implanted device is fully installed, when medical staff need the device to assist blood supply, they only need to remotely control the drive component 6 via NFC connection from outside the body. When the communication module recognizes the communication signal, the controller controls the start and stop of the drive component 6 to achieve assisted blood supply. The monitoring element 9 is used to monitor the blood oxygen concentration, pH value, and temperature value inside the femur, which facilitates medical staff to assess the patient's condition. It has the advantages of high flexibility and accurate feedback.
[0040] Specifically, this utility model also provides three data transmission methods: The first method involves an NFC coil as the communication module. The mobile terminal establishes a communication connection with the NFC coil via an NFC tag. This implementation also includes a power supply component. The monitoring element 9 collects biological information from inside the femur according to a preset timing plan and stores the data. External devices can read this data via NFC, allowing medical staff to promptly understand the specific condition inside the femur and subsequently make adaptive adjustments based on the patient's actual needs.
[0041] The second type: The communication module is specifically an NFC coil, and the mobile terminal communicates and connects to the NFC coil through the NFC tag. The power supply component uses NFC (Near Field Communication) for power supply. Based on short-range wireless communication technology, it realizes the transmission of energy and data through electromagnetic induction. This can provide less power and is suitable for low-power devices (such as micro DC motors and sensors), ensuring that the power requirements of the power supply component match the aforementioned motors and sensors.
[0042] In this embodiment, the implanted device eliminates the power supply component, further reducing the footprint of the tube 1. Specifically, the drive unit 6 and monitoring element 9 are in a shutdown state when no mobile terminal supplies power via the NFC tag. When the mobile terminal supplies power via the NFC tag, the monitoring element 9 collects biological information from inside the femur, which is read by the mobile terminal via the NFC tag, allowing medical personnel to promptly understand the specific condition inside the femur. Simultaneously, medical personnel can also control the mobile terminal via the NFC tag for communication control, with the controller controlling the drive unit 6 to drive the spiral shaft 5 for auxiliary blood supply.
[0043] The third type: The communication module is specifically a Bluetooth communication module. In this embodiment, a power supply component for power supply is also included. The monitoring element 9 can collect biological information inside the femur according to a preset timing plan and store the information data. External devices can read the data via Bluetooth communication, so that medical staff can understand the specific condition of the femur in a timely manner and make adaptive adjustments according to the patient's actual needs.
[0044] In one embodiment, the specific structure of the device is further refined. The tube body 1 is made of medical titanium alloy (Ti-6Al-4V) or tantalum metal, with a length of 5-8 cm and a diameter of 9-12 mm. The surface is sprayed with an antibacterial nano-coating (such as Ag-TiO2) to enhance biocompatibility and anti-infection ability. The specific size is adapted to the specific condition of the patient.
[0045] The leakage hole 4 is specifically designed with an elliptical through hole, with a major axis of 2 mm and a minor axis of 0.5 mm, to ensure that blood seeps evenly into the femur.
[0046] The thread pitch of the threaded positioning section 7 is set to 1 mm, and it is threadedly connected to the femoral bone tissue to enhance fixation stability.
[0047] The guide angle 8 is specifically set to a 30° angle to facilitate guidance during implantation.
[0048] In the helical delivery assembly, the helical shaft 5 is made of high-strength medical-grade cobalt-chromium-molybdenum alloy, with a diameter of 2 mm and a pitch of 1.5 mm. It is located inside the tube body 1 and its design is optimized through fluid dynamics to reduce blood shear damage. The design of the helical shaft 5 is based on CFD (Computational Fluid Dynamics) simulation optimization. By designing the pitch and rotation speed, the blood delivery efficiency is ensured to reach 0.5-1 mL / min, while the shear stress is controlled below 10 Pa to protect the integrity of blood cells.
[0049] The drive unit 6 is a miniature DC motor with a power of 0.5 W and an adjustable speed of 0-300 rpm, which is located inside the sealed end 3.
[0050] In one embodiment, the specific usage operation is as follows: Implantation process: The device is implanted into the femur through minimally invasive surgery. The sealed end 3 reaches deep into the femoral head, the threaded positioning section 7 is fixed to the bone tissue, and the open end 2 is located inside the femoral neck, connecting to the external blood supply area of the femur.
[0051] Operation method: Postoperatively, medical staff or family members send a signal via the NFC function of their smartphones. The controller then activates drive component 6, causing the spiral shaft 5 to run at 20 rpm for 5 minutes, delivering approximately 0.3 mL of blood. The monitoring element collects and stores data every 30 minutes for subsequent reading by the device. An increase of 15%-20% in the intrafemoral blood oxygen concentration indicates a significant improvement in ischemic condition.
[0052] In some extended embodiments, the controller can also run a closed-loop control algorithm based on the data collected by the sensor module to control the drainage or infusion rate of the liquid in the fluid channel, so that the oxygen partial pressure inside the femoral head is maintained within a preset range.
[0053] The controller is a microprocessor chip integrated inside the sealed end and connected to the drive unit for control.
[0054] The control algorithm is based on a blood oxygen concentration threshold (e.g., activated when below 90%), and dynamically adjusts the rotation speed using a proportional-integral-derivative control algorithm, achieving a control accuracy of ±5 rpm. The sensing element utilizes MEMS technology, reducing its size to 2 mm³, with a blood oxygen measurement error of less than ±2% and a pH error of less than ±0.1%.
[0055] Finally, it should be noted that the above embodiments are only used to illustrate the technical solutions of this utility model, and not to limit it. Although this utility model has been described in detail with reference to the foregoing embodiments, those skilled in the art should understand that modifications can still be made to the technical solutions described in the foregoing embodiments, or equivalent substitutions can be made to some of the technical features. Such modifications or substitutions do not cause the essence of the corresponding technical solutions to deviate from the spirit and scope of the technical solutions of the embodiments of this utility model.
Claims
1. A decompression implantation device for osteonecrosis, characterized in that, include: A tube, one end of which is open and the other end is sealed, is used for implantation into the femur, while the open end connects to the outside of the femur; the outer edge of the tube also has a drainage hole, which is located inside the femur; and A spiral delivery assembly includes a spiral shaft and a drive component. The spiral shaft is disposed inside the tube body, and the drive component is disposed inside the sealed end. The drive component drives the spiral shaft to rotate, and the rotation of the spiral shaft causes blood from the open end to enter the tube body and then enter the interior of the femur through the leakage hole.
2. The osteonecrosis decompression implant device according to claim 1, characterized in that, The implantable device further includes a controller and a sensing device, wherein the controller is controlled to the drive unit and the sensing device is electrically connected to the controller; The controller controls the start and stop of the drive component based on the sensing information from the sensing device.
3. The osteonecrosis decompression implant device according to claim 2, characterized in that, The sensing device includes a timer.
4. The osteonecrosis decompression implant device according to claim 2, characterized in that, The sensing device includes a communication module and a mobile terminal. The communication module is disposed on the tube body and is electrically connected to the controller. The communication module is also communicatively connected to the mobile terminal.
5. The osteonecrosis decompression implant device according to claim 4, characterized in that, It also includes a power supply assembly for supplying power, the power supply assembly being disposed inside the sealed end.
6. The osteonecrosis decompression implant device according to claim 4, characterized in that, The implantable device also includes a monitoring element for monitoring the blood oxygen concentration, pH, and temperature inside the femur. The monitoring element is electrically connected to the communication module.
7. The osteonecrosis decompression implant device according to claim 6, characterized in that, The monitoring element is located outside the sealed end.
8. The osteonecrosis decompression implant device according to claim 1, characterized in that, The outer edge of the tube is provided with a threaded positioning section, which is used to connect with the femoral thread.
9. The osteonecrosis decompression implant device according to claim 1, characterized in that, The leakage holes are spaced in multiples.
10. The osteonecrosis decompression implant device according to claim 1, characterized in that, The sealing end is provided with a guide tilt angle on its exterior.
